Indication
Citrullinemia
Citrullinemia is a rare, autosomal recessive inborn error of metabolism belonging to the family of urea cycle disorders. Read more about Citrullinemia
40 drugs 27 manufacturers
Drugs that treat it
Common Citrullinemia therapies.
SODIUM PHENYLBUTYRATE
AMMONUL (sodium benzoate/sodium phenylacetate)
BUPHENYL (sodium phenylbutyrate)
BUPHENYL (sodium phenylbutyrate)
RAVICTI (glycerol phenylbutyrate)
PHEBURANE (sodium phenylbutyrate)
BUPHENYL (sodium phenylbutyrate)
BUPHENYL (sodium phenylbutyrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCitrullinemia is a rare, autosomal recessive inborn error of metabolism belonging to the family of urea cycle disorders.
It primarily impairs the hepatic clearance of waste nitrogen, leading to profound systemic hyperammonemia and the toxic accumulation of citrulline and other metabolites in the blood, urine, and cerebrospinal fluid.
The condition encompasses type I (classic citrullinemia, caused by argininosuccinate synthetase deficiency) and type II (citrin deficiency), which affect both pediatric and adult populations.
Clinically, it presents across a spectrum ranging from catastrophic neonatal encephalopathy—characterized by lethargy, poor feeding, seizures, cerebral edema, and coma—to later-onset neuropsychiatric manifestations, ataxia, and hepatic dysfunction triggered by metabolic stress or catabolism.
- nih.gov
Citrullinemia is a rare, autosomal recessive inborn error of metabolism belonging to the family of urea cycle disorders It primarily impairs the hepatic clearance of waste nitrogen, leading to profound systemic hyperammonemia and the toxic accumulation of citrulline and other metabolites in the blood, urine, and cerebrospinal fluid The condition encompasses type I (classic citrullinemia, caused by argininosuccinate synthetase deficiency) and type II (citrin deficiency), which affect both pediatr...
- chop.edu
Citrullinemia is a rare, autosomal recessive inborn error of metabolism belonging to the family of urea cycle disorders The condition encompasses type I (classic citrullinemia, caused by argininosuccinate synthetase deficiency) and type II (citrin deficiency), which affect both pediatric and adult populations
- medlineplus.gov
It primarily impairs the hepatic clearance of waste nitrogen, leading to profound systemic hyperammonemia and the toxic accumulation of citrulline and other metabolites in the blood, urine, and cerebrospinal fluid
- nih.gov
Clinically, it presents across a spectrum ranging from catastrophic neonatal encephalopathy—characterized by lethargy, poor feeding, seizures, cerebral edema, and coma—to later-onset neuropsychiatric manifestations, ataxia, and hepatic dysfunction triggered by metabolic stress or catabolism
Personalize your experience
Follow Citrullinemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.